![Walker A. Long](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Walker A. Long
Directeur/Membre du Conseil chez
BioMarck Pharmaceuticals Ltd.
Profil
Dr. Walker A. Long, MD, is Chief Medical Officer & VP-Drug Development at Biolex Therapeutics, Inc. He is on the Board of Directors at BioMarck Pharmaceuticals Ltd.
Dr. Long was previously employed as Vice President-Clinical Development by AtheroGenics, Inc., Senior Vice President-Project Operations by Cato Research Ltd, a Faculty Member by University of North Carolina at Chapel Hill, and a Principal by Wellcome Research Laboratories.
He received his undergraduate degree from the University of North Carolina at Chapel Hill and a doctorate degree from the University of North Carolina at Chapel Hill.
Postes actifs de Walker A. Long
| Sociétés | Poste | Début |
|---|---|---|
BioMarck Pharmaceuticals Ltd.
 BioMarck Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops new drugs for the treatment of pulmonary diseases and disorders | Directeur/Membre du Conseil | - |
Anciens postes connus de Walker A. Long
| Sociétés | Poste | Fin |
|---|---|---|
Wellcome Research Laboratories | Corporate Officer/Principal | - |
The University of North Carolina at Asheville
 The University of North Carolina at Asheville Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Cato Research LLC
 Cato Research LLC Miscellaneous Commercial ServicesCommercial Services Specializes in drug development support services for clients in the pharmaceutical, biotechnology and medical device industries | Corporate Officer/Principal | - |
AtheroGenics, Inc.
 AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs for the treatment of chronic inflammatory diseases | Corporate Officer/Principal | - |
Biolex Therapeutics, Inc.
 Biolex Therapeutics, Inc. Medical DistributorsDistribution Services Develops and produces drugs | Directeur Technique/Scientifique/R&D | - |
Formation de Walker A. Long
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
10
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs for the treatment of chronic inflammatory diseases | Health Technology |
Biolex Therapeutics, Inc.
Biolex Therapeutics, Inc. Medical DistributorsDistribution Services Develops and produces drugs | Distribution Services |
BioMarck Pharmaceuticals Ltd.
BioMarck Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops new drugs for the treatment of pulmonary diseases and disorders | Health Technology |
Cato Research LLC
Cato Research LLC Miscellaneous Commercial ServicesCommercial Services Specializes in drug development support services for clients in the pharmaceutical, biotechnology and medical device industries | Commercial Services |
Wellcome Research Laboratories | |
The University of North Carolina at Asheville
The University of North Carolina at Asheville Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of North Carolina at Charlotte
 The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
